319 related articles for article (PubMed ID: 14705962)
1. New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?
Van Kuilenburg AB; Stroomer AE; Van Lenthe H; Abeling NG; Van Gennip AH
Biochem J; 2004 Apr; 379(Pt 1):119-24. PubMed ID: 14705962
[TBL] [Abstract][Full Text] [Related]
2. A pivotal role for beta-aminoisobutyric acid and oxidative stress in dihydropyrimidine dehydrogenase deficiency?
van Kuilenburg AB; Stroomer AE; Abeling NG; van Gennip AH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1103-6. PubMed ID: 17065072
[TBL] [Abstract][Full Text] [Related]
3. beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.
van Kuilenburg AB; Meinsma R; Beke E; Assmann B; Ribes A; Lorente I; Busch R; Mayatepek E; Abeling NG; van Cruchten A; Stroomer AE; van Lenthe H; Zoetekouw L; Kulik W; Hoffmann GF; Voit T; Wevers RA; Rutsch F; van Gennip AH
Hum Mol Genet; 2004 Nov; 13(22):2793-801. PubMed ID: 15385443
[TBL] [Abstract][Full Text] [Related]
4. Beta-alanine and beta-aminoisobutyric acid levels in two siblings with dihydropyrimidinase deficiency.
van Kuilenburg AB; Stroomer AE; Bosch AM; Duran M
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):825-9. PubMed ID: 18600547
[TBL] [Abstract][Full Text] [Related]
5. A neonate with recurrent vomiting and generalized hypotonia diagnosed with a deficiency of dihydropyrimidine dehydrogenase.
Brussel W; van Kuilenburg AB; Janssens PM
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1099-102. PubMed ID: 17065071
[TBL] [Abstract][Full Text] [Related]
6. Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy.
Lee A; Ezzeldin H; Fourie J; Diasio R
Clin Adv Hematol Oncol; 2004 Aug; 2(8):527-32. PubMed ID: 16163233
[TBL] [Abstract][Full Text] [Related]
7. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
Ogura K
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1041-8. PubMed ID: 16912518
[TBL] [Abstract][Full Text] [Related]
8. Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine.
Ohse M; Matsuo M; Ishida A; Kuhara T
J Mass Spectrom; 2002 Sep; 37(9):954-62. PubMed ID: 12271438
[TBL] [Abstract][Full Text] [Related]
9. Degradation of the pyrimidine bases uracil and thymine by Escherichia coli B.
Patel BN; West TP
Microbios; 1987; 49(199):107-13. PubMed ID: 3553866
[TBL] [Abstract][Full Text] [Related]
10. Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea.
Meinsma R; Fernandez-Salguero P; Van Kuilenburg AB; Van Gennip AH; Gonzalez FJ
DNA Cell Biol; 1995 Jan; 14(1):1-6. PubMed ID: 7832988
[TBL] [Abstract][Full Text] [Related]
11. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract][Full Text] [Related]
12. The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil.
Mattison LK; Fourie J; Hirao Y; Koga T; Desmond RA; King JR; Shimizu T; Diasio RB
Clin Cancer Res; 2006 Jan; 12(2):549-55. PubMed ID: 16428499
[TBL] [Abstract][Full Text] [Related]
13. Relationships among plasma [2-(13)C]uracil concentrations, breath (13)CO(2) expiration, and dihydropyrimidine dehydrogenase (DPD) activity in the liver in normal and dpd-deficient dogs.
Inada M; Hirao Y; Koga T; Itose M; Kunizaki J; Shimizu T; Sato H
Drug Metab Dispos; 2005 Mar; 33(3):381-7. PubMed ID: 15616154
[TBL] [Abstract][Full Text] [Related]
14. Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.
Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB
Pharmacogenet Genomics; 2007 Nov; 17(11):973-87. PubMed ID: 18075467
[TBL] [Abstract][Full Text] [Related]
15. [Dihydropyrimidine dehydrogenase deficiency].
Kouwaki M; Wada Y
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):490-3. PubMed ID: 9590110
[No Abstract] [Full Text] [Related]
16. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.
Ezzeldin HH; Lee AM; Mattison LK; Diasio RB
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8699-705. PubMed ID: 16361556
[TBL] [Abstract][Full Text] [Related]
17. Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.
Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB
Pharmacogenet Genomics; 2008 Jan; 18(1):25-35. PubMed ID: 18216719
[TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
[TBL] [Abstract][Full Text] [Related]
19. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.
van Kuilenburg AB
Eur J Cancer; 2004 May; 40(7):939-50. PubMed ID: 15093568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
